NovoCure NVCR Q2 2025 earnings
Reported July 24, 2025 · Before market open
Revenue$158.8MIn line
EPS-$0.36Beat by $0.03
Revenue estimate$158.8M
EPS estimate-$0.39
Next report
Date not yet announcedFinancials
Q2 2025Valuation & ratios
Versus estimates
Revenue
Diluted EPS
Ask the moment NovoCure reports.
Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.
Connect your AI
Claude
Questions, answered.
- When did NovoCure report Q2 2025 earnings?
- NovoCure (NVCR) reported Q2 2025 earnings on July 24, 2025 before market open.
- What were NovoCure's Q2 2025 revenue and EPS?
- NovoCure reported revenue of $158.8M and eps of $-0.36 for Q2 2025.
- Did NovoCure beat estimates in Q2 2025?
- Revenue missed the consensus estimate of $158.8M by $4.9K. EPS beat the consensus estimate of $-0.39 by $0.03.
- How did NovoCure's Q2 2025 results compare year-over-year?
- Compared to the same quarter a year prior, revenue grew 5.6% from $150.4M a year earlier and eps declined 16.1% from $-0.31.
- Where can I find NovoCure's Q2 2025 SEC filings?
- You can read the 10-Q periodic report (0001645113-25-000029) directly on SEC EDGAR. The filing index links above go to sec.gov.